Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
STAT

Opinion: How traditional pharmacies can survive the Amazon threat

Traditional pharmacies are likely to see their market share tumble unless they evolve and offer things that the disruptors can't.
Source: JEAN-CHRISTOPHE VERHAEGEN/AFP/Getty Images

Are traditional pharmacies doomed to the same fate as Borders, Blockbuster, and Sears? The threat is real.

Companies like Capsule and PillPack are redesigning the pharmacy for the digital age. In addition to making it effortless to get prescription medications, these disruptors are bent on cutting out the physical store. This summer, Amazon bought PillPack, bringing heft, customer-service expertise, and gargantuan corporate ambition to the fight.

Yet I believe there is hope for traditional pharmacies — at least for those that adapt and innovate. Brick-and-mortar stores can offer value not available from app-and-delivery businesses. Some of that value is already being harnessed by traditional pharmacies, but most isn’t. Here

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min read
STAT+: How UnitedHealth Turned A Questionable Artery-screening Program Into A Gold Mine
This is the second in a periodic series from STAT about how UnitedHealth Group wields its unrivaled physician empire to boost profits and expand its influence.
STAT1 min read
STAT+: Health Care’s ‘Pepsi Challenge’: Doctors’ Offices Are Testing AI Tools In Head-to-head Pilots
A half-dozen companies dominate AI scribe contracts with health systems, including Microsoft’s Nuance, Nabla, and Epic-partnered Abridge.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Roche Obesity Drug Data, Fallout From The Menendez Verdict, And More
Roche reported positive early data from an obesity drug candidate, bolstering the case it could become a player in the competitive weight loss medicine field.

Related